PP
ARQT icon

PDT Partners’s Arcutis Biotherapeutics ARQT Stock Holding History

PDT Partners’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.65M Hold
155,075
– – 0.22% 156
2025
Q4 		$4.5M Buy
155,075
+967
+0.6% +$24.8K 0.29% 117
2025
Q3 		$2.9M Sell
154,108
-36,875
-19% -$582K 0.18% 194
2025
Q2 		$2.68M Sell
190,983
-126,482
-40% -$1.77M 0.15% 235
2025
Q1 		$4.97M Sell
317,465
-2,250
-0.7% -$31.7K 0.35% 72
2024
Q4 		$4.45M Hold
319,715
– – 0.39% 52
2024
Q3 		$2.97M Hold
319,715
– – 0.26% 118
2024
Q2 		$2.97M Sell
319,715
-511
-0.2% -$4.62K 0.28% 112
2024
Q1 		$3.17M Buy
+320,226
New +$2.39M 0.3% 102
2023
Q4 		– Sell
-195,081
Closed -$1.04M – 541
2023
Q3 		$1.04M Buy
195,081
+74,503
+62% +$634K 0.13% 275
2023
Q2 		$1.15M Sell
120,578
-34,906
-22% -$387K 0.16% 218
2023
Q1 		$1.71M Buy
155,484
+97,607
+169% +$1.41M 0.23% 155
2022
Q4 		$857K Buy
57,877
+45,204
+357% +$790K 0.14% 267
2022
Q3 		$242K Buy
+12,673
New +$287K 0.04% 656

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return